Medicilon : Writing

Introduction of GLP-1s

Introduction of GLP-1s

A Story by Medicilon


Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone. GLP-1 exists in two equally bioactive forms, GLP-1 (7-37) amide and GL..
Caco-2 Cell Permeability Assay

Caco-2 Cell Permeability Assay

A Story by Medicilon


Caco-2 cells are human colon cancer cell line commonly used to simulate the characteristics and functions of the epithelial cell layer of the human sm..
Medicilon was selected into the SSE Science and Technology Innovation Board 100 Index, R&D intensity

Medicilon was selected into the SSE Science and Te..

A Story by Medicilon


On August 7, 2023, the Shanghai Stock Exchange officially launched the SSE Science and Technology Innovation Board 100 Index, a new index added to the..
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug resea

Fosun Health Capital reached a cooperation agreeme..

A Story by Medicilon


On July 25, 2023, Fosun Health Capital established by Fosun Pharma(stock code:600196.SH), reached a strategic partnership with Medicilon(..
Medicilon Assists Yuyao Biotech's STAT3 dual phosphorylation inhibitor YY201 has been approved for c

Medicilon Assists Yuyao Biotech's STAT3 dual phosp..

A Story by Medicilon


Shanghai Medicilon Inc. (Medicilon), as a partner of Yuyao Biotech, provided YY201 with pharmaceutical research services (including raw materials and ..
Medicilon interview with Dr. Xin Dong - In the field of immunotherapy, where the fierce competition

Medicilon interview with Dr. Xin Dong - In the fie..

A Story by Medicilon


To this end, Shanghai Medicilon Inc. (Medicilon) interviewed Dr. Xin Dong to get a glimpse of his profound insights in the field of immunotherapy, and..
The Medicilon DMPK team was praised again, and Dr. Yan Feng, CEO of Leading Tac Pharma, came to pres

The Medicilon DMPK team was praised again, and Dr...

A Story by Medicilon


On June 28, Chuansha Park of Shanghai Medicilon Inc. (Medicilon) welcomed familiar customers - Dr. Yan Feng, Founder and CEO of Leading Tac Pharma, Dr..
Fudan University, School of Management "Science and Technology Entrepreneur Camp" entered Medicilon:

Fudan University, School of Management "Science an..

A Story by Medicilon


On July 14, Professor Xiongwen Lu, Dean of the School of Management of Fudan University, led the professor group of Fudan School of Management and the..
Medicilon Assisted - The IND application of BIOT-001, the first self-developed new drug of Biotime B

Medicilon Assisted - The IND application of BIOT-0..

A Story by Medicilon


On July 14, the IND application for the BIOT-001 project targeting the S1P1 target declared by Biotime Biotechnology obtained the US FDA's clinical im..
Medicilon Assist - The IND application for the first new drug NB002 of Neologics Bioscience was appr

Medicilon Assist - The IND application for the fir..

A Story by Medicilon


Recently, Neologics Bioscience announced that its research and development pipeline NB002 for the treatment of solid tumors has successfully passed th..